Dbv Technologies ADR (DBVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DBVT | AMGN | BMY | VRTX | GILD |
| Company | Dbv Technologies ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.5090 | 293.55 | 59.98 | 456.58 | 90.75 |
| High | 0.5090 | 296.93 | 60.68 | 461.88 | 91.37 |
| Low | 0.4800 | 293.50 | 59.78 | 455.83 | 90.34 |
| Last | 0.4937 | 295.50 | 59.54 | 457.94 | 90.76 |
| Change | +0.0247 | +0.97 | +0.67 | +6.97 | +0.57 |
| % Change | +5.27% | +0.33% | +1.14% | +1.55% | +0.63% |
| Volume | 15,832 | 124,226 | 1,104,615 | 63,161 | 228,494 |
| 20-Day Average Volume | 111,702 | 2,908,743 | 12,000,264 | 1,335,859 | 7,178,854 |
| Previous Close | 0.4690 | 294.53 | 58.87 | 450.97 | 90.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6480 | 305.27 | 56.65 | 477.13 | 91.06 |
| 20-Day Raw Stochastic | 21.47% | 39.88% | 89.60% | 21.19% | 38.30% |
| 20-Day Relative Strength | 37.96% | 41.69% | 64.84% | 45.16% | 56.27% |
| Weighted Alpha | -71.16 | +3.31 | +30.83 | +22.12 | +25.52 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Last Month's Opinion | 40% Sell | 8% Buy | 72% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.51% since 11/18/24 | +6.39% since 11/18/24 | +5.90% since 11/18/24 | -1.31% since 11/18/24 | +2.86% since 11/18/24 |
| Low | 0.4409 on 11/19/24 | 275.56 on 11/19/24 | 56.10 on 11/19/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.5900 on 11/19/24 | 296.93 on 11/25/24 | 60.68 on 11/25/24 | 463.90 on 11/19/24 | 91.30 on 11/25/24 |
| 1-Month | |||||
| %Chg | -39.08% since 10/25/24 | -6.44% since 10/25/24 | +15.85% since 10/25/24 | -3.52% since 10/25/24 | +2.24% since 10/25/24 |
| Low | 0.4409 on 11/19/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.8560 on 10/28/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -42.62% since 08/23/24 | -9.80% since 08/23/24 | +25.03% since 08/23/24 | -4.23% since 08/23/24 | +18.60% since 08/23/24 |
| Low | 0.4409 on 11/19/24 | 275.56 on 11/19/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 76.42 on 08/26/24 |
| High | 1.0900 on 10/23/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -56.70% since 05/24/24 | -3.03% since 05/24/24 | +45.85% since 05/24/24 | +0.86% since 05/24/24 | +38.54% since 05/24/24 |
| Low | 0.4409 on 11/19/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 1.2868 on 05/29/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 45,259 | 158,319,600 | 119,398,784 | 116,137,848 | 112,400,728 |
| Shares Outstanding, K | 96,502 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 15,730,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -72,730,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 1,070,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -30,440,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.66 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.08 | 49.77 | 0.00 | 20.26 |